Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil

37Citations
Citations of this article
126Readers
Mendeley users who have this article in their library.

Abstract

Laboratory confirmation of Zika virus (ZIKV) infection during pregnancy is challenging due to cross-reactivity with dengue virus (DENV) and limited knowledge about the kinetics of anti-Zika antibody responses during pregnancy. We described ZIKV and DENV serological markers and the maternal-fetal transfer of antibodies among mothers and neonates after the ZIKV microcephaly outbreak in Northeast Brazil (2016). We included 89 microcephaly cases and 173 neonate controls at time of birth and their mothers. Microcephaly cases were defined as newborns with a particular head circumference (2 SD below the mean). Two controls without microcephaly were matched by the expected date of delivery and area of residence. We tested maternal serum for recent (ZIKV genome, IgM and IgG3 anti-NS1) and previous (ZIKV and DENV neutralizing antibodies [NAbs]) markers of infection. Multiple markers of recent or previous ZIKV and DENV infection in mothers were analyzed using principal component analysis (PCA). At delivery, 5.6% of microcephaly case mothers and 1.7% of control mothers were positive for ZIKV IgM. Positivity for ZIKV IgG3 anti-NS1 was 8.0% for case mothers and 3.5% for control mothers. ZIKV NAbs was slightly higher among mothers of cases (69.6%) than that of mothers of controls (57.2%; p = 0.054). DENV exposure was detected in 85.8% of all mothers. PCA discriminated two distinct components related to recent or previous ZIKV infection and DENV exposure. ZIKV NAbs were higher in newborns than in their corresponding mothers (p<0.001). We detected a high frequency of ZIKV exposure among mothers after the first wave of the ZIKV outbreak in Northeast Brazil. However, we found low sensitivity of the serological markers to recent infection (IgM and IgG3 anti-NS1) in perinatal samples of mothers of microcephaly cases. Since the neutralization test cannot precisely determine the time of infection, testing for ZIKV immune status should be performed as early as possible and throughout pregnancy to monitor acute Zika infection in endemic areas.

References Powered by Scopus

The global distribution and burden of dengue

7096Citations
N/AReaders
Get full text

Zika virus outbreak on Yap Island, Federated States of Micronesia

2413Citations
N/AReaders
Get full text

FcRn: The neonatal Fc receptor comes of age

1893Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies during the COVID-19 Pandemic

310Citations
N/AReaders
Get full text

Compromised SARS-CoV-2-specific placental antibody transfer

149Citations
N/AReaders
Get full text

mRNA Covid-19 vaccines in pregnancy: A systematic review

56Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Castanha, P. M. S., Souza, W. V., Braga, C., Araújo, T. V. B. de, Ximenes, R. A. A., Albuquerque, M. de F. P. M., … Martelli, C. M. T. (2018). Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil. PLoS Neglected Tropical Diseases, 13(3). https://doi.org/10.1371/journal.pntd.0007246

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 46

67%

Researcher 13

19%

Professor / Associate Prof. 7

10%

Lecturer / Post doc 3

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 28

46%

Immunology and Microbiology 16

26%

Nursing and Health Professions 9

15%

Agricultural and Biological Sciences 8

13%

Save time finding and organizing research with Mendeley

Sign up for free